Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1953 1
1954 4
1956 3
1957 2
1958 1
1959 4
1960 2
1961 1
1962 9
1963 7
1964 14
1965 2
1966 12
1967 5
1968 10
1969 15
1970 19
1971 15
1972 9
1973 14
1974 11
1975 18
1976 10
1977 10
1978 18
1979 13
1980 14
1981 7
1982 6
1983 12
1984 10
1985 10
1986 10
1987 11
1988 11
1989 13
1990 10
1991 13
1992 14
1993 18
1994 7
1995 8
1996 22
1997 12
1998 15
1999 17
2000 24
2001 20
2002 12
2003 20
2004 13
2005 18
2006 16
2007 8
2008 16
2009 15
2010 16
2011 21
2012 22
2013 20
2014 9
2015 11
2016 7
2017 10
2018 14
2019 28
2020 12
2021 27
2022 23
2023 12

Text availability

Article attribute

Article type

Publication date

Search Results

838 results

Results by year

Filters applied: . Clear all
Page 1
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.
Hewitt SL, Bailey D, Zielinski J, Apte A, Musenge F, Karp R, Burke S, Garcon F, Mishra A, Gurumurthy S, Watkins A, Arnold K, Moynihan J, Clancy-Thompson E, Mulgrew K, Adjei G, Deschler K, Potz D, Moody G, Leinster DA, Novick S, Sulikowski M, Bagnall C, Martin P, Lapointe JM, Si H, Morehouse C, Sedic M, Wilkinson RW, Herbst R, Frederick JP, Luheshi N. Hewitt SL, et al. Among authors: zielinski j. Clin Cancer Res. 2020 Dec 1;26(23):6284-6298. doi: 10.1158/1078-0432.CCR-20-0472. Epub 2020 Aug 17. Clin Cancer Res. 2020. PMID: 32817076
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs.
Hewitt SL, Bai A, Bailey D, Ichikawa K, Zielinski J, Karp R, Apte A, Arnold K, Zacharek SJ, Iliou MS, Bhatt K, Garnaas M, Musenge F, Davis A, Khatwani N, Su SV, MacLean G, Farlow SJ, Burke K, Frederick JP. Hewitt SL, et al. Among authors: zielinski j. Sci Transl Med. 2019 Jan 30;11(477):eaat9143. doi: 10.1126/scitranslmed.aat9143. Sci Transl Med. 2019. PMID: 30700577
Analysis of tumour site concordance.
Krewski D, Rice JM, Bird M, Milton B, Collins B, Lajoie P, Billard M, Grosse Y, Cogliano VJ, Caldwell JC, Rusyn II, Portier CJ, Melnick RL, Little J, Zielinski JM. Krewski D, et al. Among authors: zielinski jm. In: Baan RA, Stewart BW, Straif K, editors. Tumour Site Concordance and Mechanisms of Carcinogenesis. Lyon (FR): International Agency for Research on Cancer; 2019. Chapter 21. In: Baan RA, Stewart BW, Straif K, editors. Tumour Site Concordance and Mechanisms of Carcinogenesis. Lyon (FR): International Agency for Research on Cancer; 2019. Chapter 21. PMID: 33979094 Free Books & Documents. Review. No abstract available.
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y,… See abstract for full author list ➔ Lim SS, et al. Among authors: zielinski jm. Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8. Lancet. 2012. PMID: 23245609 Free PMC article.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease. Rabe KF, et al. Among authors: zielinski j. Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16. Am J Respir Crit Care Med. 2007. PMID: 17507545 Review.
The Effect of Beta-Alanine versus Alkaline Agent Supplementation Combined with Branched-Chain Amino Acids and Creatine Malate in Highly-Trained Sprinters and Endurance Athletes: A Randomized Double-Blind Crossover Study.
Durkalec-Michalski K, Kusy K, Ciekot-Sołtysiak M, Zieliński J. Durkalec-Michalski K, et al. Among authors: zielinski j. Nutrients. 2019 Aug 21;11(9):1961. doi: 10.3390/nu11091961. Nutrients. 2019. PMID: 31438535 Free PMC article. Clinical Trial.
Overview of biological mechanisms of human carcinogens.
Birkett N, Al-Zoughool M, Bird M, Baan RA, Zielinski J, Krewski D. Birkett N, et al. Among authors: zielinski j. J Toxicol Environ Health B Crit Rev. 2019;22(7-8):288-359. doi: 10.1080/10937404.2019.1643539. Epub 2019 Oct 20. J Toxicol Environ Health B Crit Rev. 2019. PMID: 31631808 Review.
838 results